Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-609-9 | CAS number: 1333-86-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: other routes
Administrative data
- Endpoint:
- repeated dose toxicity: other route
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- unsuitable test system
Data source
Reference
- Reference Type:
- publication
- Title:
- Nano-Sized Carbon Black Exposure Exacerbates Atherosclerosis in LDL-Receptor Knockout Mice
- Author:
- Niwa Y, Hiura Y, Murayama T, Yokode M, Iwai N
- Year:
- 2 007
- Bibliographic source:
- Circulation Journal 71: 1157 – 1161
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Repeated intratracheal administration of an approximate total dose of 444 mg/kg carbon black within 10 weeks to investigate the effects of CB on the development of atherosclerosis
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Carbon black
- EC Number:
- 215-609-9
- EC Name:
- Carbon black
- Cas Number:
- 1333-86-4
- Molecular formula:
- C
- IUPAC Name:
- carbon
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: Low-density lipoprotein receptor knockout mice (LDLR/KO)
- Sex:
- male
Administration / exposure
- Route of administration:
- other: intratracheal
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 10 weeks
- Frequency of treatment:
- One instillation (1mg) per week
Doses / concentrations
- Dose / conc.:
- 1 other: mg/animal per week
- Remarks:
- in the absence or presence of cholesterol
- No. of animals per sex per dose:
- 5 male / group; 4 groups
- Control animals:
- yes
- Details on study design:
- Two groups of mice were subjected to a 10-week endotracheal dispersion of autoclaved CB (1 mg per animal/week) and given isoenergy diets containing 0% or 0.51% Chol. Another 2 groups of mice underwent intratracheal dispersion of air only under isonergy diets with 0% or 0.51% Chol. Intratracheal dispersion of CB and air was performed once a week for 10 weeks under light ether anesthesia
Results and discussion
Applicant's summary and conclusion
- Conclusions:
- No conclusions can be drawn on the repeated dose toxicity of carbon black. The relevance of the non-validated test system is unclear.
- Executive summary:
The experiment was conducted with two groups of low-density lipoprotein receptor knockout mice (LDLR/KO) fed with isoenergetic diets in the absence of cholesterol or presence of 0.51% cholesterol.
Carbon black was not detected by electron microscopy in aortas, livers, kidneys, and spleen of LDLR/KO mice after repeated intratracheal administration.
An accelerated development of atherosclerosis in the mice was studied by examination of Oil red O stained aortic tissue. The stained plaque area was quantifi ed. Mice fed with cholesterol only and those treated with carbon black in addition had a statistically signifi cantly more extensive staining (7 and 13% area stained, respectively). Vehicle or carbon black treated mice showed both about 3% stained area in the absence of cholesterol. The authors interpreted these results that carbon black treatment accelerated development of atherosclerosis.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.